Skip to content
DraconiticResearch
Search Sources API
186,541 studies31 sourcesUpdated 11 min ago
Peer-reviewedCC BYFrontiers in cardiovascular medicine

Atrial fibroblast metabolic reprogramming in atrial fibrillation: a candidate mechanism within multicellular atrial cardiomyopathy

  1. 1Department of Cardiology, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University , , ,

Related

  1. Anthracycline Cardiotoxicity as Multicellular Network Failure: Cardiac Niche Reprogramming and Pathological Cell–Cell Communication
    Shuhui Wang, Quanquan Ding, Siyue Ding +2
    Journal of the American Heart AssociationPeer-reviewedCC BY-NC-NDCardiovascular medicineCrossref
  2. Fibroblast Activation Protein Inhibitor Positron Emission Tomography Imaging in Atrial Fibrillation: Current Evidence and Future Perspectives
    Yi Xu, Huiyi Qiu, Chuxian Guo +5
    Reviews in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  3. Recurrence Rates and Outcomes After First Detected Atrial Fibrillation Episode in a Contemporary Hypertrophic Cardiomyopathy Center
    Mauro Rogerio de Barros Wanderley, Martin S. Maron, Jonathan S. Silver +3
    Journal of cardiovascular development and diseasePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  4. Life-long management of atrial fibrillation in a patient with hypertrophic obstructive cardiomyopathy following alcohol septal ablation: A10-year follow-up case report
    Keitaro Akita, Yoshihisa Naruse, Makoto Sano +2
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textCardiovascular medicineJ-STAGE
  5. A TERRA-NONO axis drives fibroblast reprogramming in cancer
    Emery Di Cicco, Jovan Isma, Stefano Sol +10
    Science AdvancesPeer-reviewedCC BYOncologyCrossref
BibTeX
@article{jiang2026atrial,
  title = {{Atrial fibroblast metabolic reprogramming in atrial fibrillation: a candidate mechanism within multicellular atrial cardiomyopathy}},
  author = {Xiao-hai Jiang and Run-zhong Wang and Ya-wen Sheng and Ling Liu},
  journal = {Frontiers in cardiovascular medicine},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13655352},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Atrial fibroblast metabolic reprogramming in atrial fibrillation: a candidate mechanism within multicellular atrial cardiomyopathy
AU  - Xiao-hai Jiang
AU  - Run-zhong Wang
AU  - Ya-wen Sheng
AU  - Ling Liu
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in cardiovascular medicine
UR  - https://europepmc.org/article/PMC/PMC13655352
SN  - 2297-055X
ER  -